0002152199-26-000001.txt : 20260828 0002152199-26-000001.hdr.sgml : 20260828 20260827174227 ACCESSION NUMBER: 0002152199-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260828 DATE AS OF CHANGE: 20260827 EFFECTIVENESS DATE: 20260828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Candor Therapeutics Inc. CENTRAL INDEX KEY: 0002152199 ORGANIZATION NAME: EIN: 423369514 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595702 FILM NUMBER: 261332074 BUSINESS ADDRESS: STREET 1: 131 CONTINENTAL DRIVE, SUITE 305 CITY: NEWARK STATE: DE ZIP: 19713 BUSINESS PHONE: 408-757-6830 MAIL ADDRESS: STREET 1: 131 CONTINENTAL DRIVE, SUITE 305 CITY: NEWARK STATE: DE ZIP: 19713 D 1 primary_doc.xml X0708 D LIVE 0002152199 Candor Therapeutics Inc. 710 Lakeway Drive, Suite 200 Sunnyvale CA CALIFORNIA 94085 408-757-6830 DELAWARE None None Corporation true 2026 Ramkumar Mandalam 710 Lakeway Drive, Suite 200 Sunnyvale CA CALIFORNIA 94085 Executive Officer Director Mohan Srinivasan 710 Lakeway Drive, Suite 200 Sunnyvale CA CALIFORNIA 94085 Director Biotechnology Decline to Disclose 06b false 2026-08-17 false true Simple Agreement for Future Equity false 0 750000 50000 700000 false 2 0 0 0 Other than the payment of salaries and other compensation and benefits no officer, director, or promoter will receive any payments from the proceeds of this offering. false Candor Therapeutics Inc. /s/ Ramkumar Mandalam Ramkumar Mandalam Chief Executive Officer 2026-08-27